Autologous OC-L Vaccine and Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
HOT: HIPEC in Ovarian Cancer as Initial Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Tivozanib As Maintenance Therapy In GYN
- Status
- TERMINATED
- Phase
- PHASE2
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients
- Status
- COMPLETED
- Phase
- PHASE2
PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
- Status
- COMPLETED
- Phase
- PHASE2
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Validation of a Nutrition Screening Tool
- Status
- COMPLETED
- Phase
- N/A
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
- Status
- WITHDRAWN
- Phase
- PHASE2
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- NA
Accelerating Gastrointestinal Recovery
- Status
- COMPLETED
- Phase
- PHASE3